← All organizations

Thor Medical

Thor Medical

For profitWebsite ↗

Also known as: Nordic Nanovector

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Oct 4, 2018

Timeline

2000s

Jun 1, 2009
Thor Medical— Founded

Drugs by trial phase (2 distinct, 4 trials)

Phase 2 (1 own, 0 via acquisition)

lilotomab

Phase 1 (1 own, 0 via acquisition)

rituximab

Indications

Studied for

Recent trials (4)

NCT03806179Lead sponsorPhase 1Oct 4, 2018
NCT02657447Lead sponsorPhase 1May 1, 2017
NCT02658968Lead sponsorPhase 1Jan 1, 2016
NCT01796171Lead sponsorPhase 1/Phase 2Dec 1, 2012

Details

Founded: Oslo, NO Jun 1, 2009
Last known activity: Oct 4, 2018